
|Articles|September 1, 2003
Reimbursement Achievable for Biologics in Psoriasis
The January FDA clearance of Biogen Inc.'s Amevive (alefacept) for the treatment of moderate-to-severe chronic plaque psoriasis officially ushered in the era of biologic treatments for dermatologists.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Chronic Hand Eczema: Treatment Gaps, New Options, and Clinical Trial End Points
2
David Rosmarin, MD, on CHE Heterogeneity and Unmet Needs in AD and Vitiligo
3
Clinique's Daily Calm Merges Clinical Efficacy with Color Cosmetics for Sensitive Skin
4
First HA Injectable for Neck Wrinkles Cleared by FDA
5












